The effects of smoking on metabolic syndrome and its components using causal methods in the Iranian Population

Background: The aim of this study was to estimate the effect of smoking on metabolic syndrome (MS) and its components applying inverse probability-of-treatment weighting (IPTW) and propensity score (PS) matching. Methods: Using data from Tehran Lipid and Glucose Study, 4857 participants aged over 20...

Full description

Bibliographic Details
Main Authors: Farzad Khodamoradi, Maryam Nazemipour, Nasrin Mansournia, Kamran Yazdani, Davood Khalili, Mohammad Ali Mansournia
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:International Journal of Preventive Medicine
Subjects:
Online Access:http://www.ijpvmjournal.net/article.asp?issn=2008-7802;year=2021;volume=12;issue=1;spage=118;epage=118;aulast=Khodamoradi
_version_ 1818558954111762432
author Farzad Khodamoradi
Maryam Nazemipour
Nasrin Mansournia
Kamran Yazdani
Davood Khalili
Mohammad Ali Mansournia
author_facet Farzad Khodamoradi
Maryam Nazemipour
Nasrin Mansournia
Kamran Yazdani
Davood Khalili
Mohammad Ali Mansournia
author_sort Farzad Khodamoradi
collection DOAJ
description Background: The aim of this study was to estimate the effect of smoking on metabolic syndrome (MS) and its components applying inverse probability-of-treatment weighting (IPTW) and propensity score (PS) matching. Methods: Using data from Tehran Lipid and Glucose Study, 4857 participants aged over 20 years with information on smoking and confounders in the third phase (2005–2008) were included, and the MS was assessed in the fifth phase (2011–2014). IPTW and PS matching were used to adjust for confounders. Results: Based on average treatment effect (ATE) estimates, smoking decreased the risk of hypertension (RR: 0.62; 95% CI: 0.43, 0.88), but increased the risk of low HDL cholesterol (1.20; 0.98, 1.48). Similarly, the average treatment effect in the treated (ATT) estimates using IPTW and PS matching suggested that smoking decreased the risk of hypertension (0.63; 0.52, 0.76, and 0.68; 0.54, 0.85), and increased the risk of low HDL cholesterol (1.24; 1.07, 1.43, and 1.28; 1.06, 1.54), respectively. Conclusions: Smoking seems to increase the risk of low HDL cholesterol but decreases the risk of hypertension.
first_indexed 2024-12-14T00:19:02Z
format Article
id doaj.art-122db28ef56049db98be6e917571da8c
institution Directory Open Access Journal
issn 2008-7802
2008-8213
language English
last_indexed 2024-12-14T00:19:02Z
publishDate 2021-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series International Journal of Preventive Medicine
spelling doaj.art-122db28ef56049db98be6e917571da8c2022-12-21T23:25:18ZengWolters Kluwer Medknow PublicationsInternational Journal of Preventive Medicine2008-78022008-82132021-01-0112111811810.4103/ijpvm.ijpvm_45_21The effects of smoking on metabolic syndrome and its components using causal methods in the Iranian PopulationFarzad KhodamoradiMaryam NazemipourNasrin MansourniaKamran YazdaniDavood KhaliliMohammad Ali MansourniaBackground: The aim of this study was to estimate the effect of smoking on metabolic syndrome (MS) and its components applying inverse probability-of-treatment weighting (IPTW) and propensity score (PS) matching. Methods: Using data from Tehran Lipid and Glucose Study, 4857 participants aged over 20 years with information on smoking and confounders in the third phase (2005–2008) were included, and the MS was assessed in the fifth phase (2011–2014). IPTW and PS matching were used to adjust for confounders. Results: Based on average treatment effect (ATE) estimates, smoking decreased the risk of hypertension (RR: 0.62; 95% CI: 0.43, 0.88), but increased the risk of low HDL cholesterol (1.20; 0.98, 1.48). Similarly, the average treatment effect in the treated (ATT) estimates using IPTW and PS matching suggested that smoking decreased the risk of hypertension (0.63; 0.52, 0.76, and 0.68; 0.54, 0.85), and increased the risk of low HDL cholesterol (1.24; 1.07, 1.43, and 1.28; 1.06, 1.54), respectively. Conclusions: Smoking seems to increase the risk of low HDL cholesterol but decreases the risk of hypertension.http://www.ijpvmjournal.net/article.asp?issn=2008-7802;year=2021;volume=12;issue=1;spage=118;epage=118;aulast=Khodamoradimetabolic syndromepropensity scoresmoking.
spellingShingle Farzad Khodamoradi
Maryam Nazemipour
Nasrin Mansournia
Kamran Yazdani
Davood Khalili
Mohammad Ali Mansournia
The effects of smoking on metabolic syndrome and its components using causal methods in the Iranian Population
International Journal of Preventive Medicine
metabolic syndrome
propensity score
smoking.
title The effects of smoking on metabolic syndrome and its components using causal methods in the Iranian Population
title_full The effects of smoking on metabolic syndrome and its components using causal methods in the Iranian Population
title_fullStr The effects of smoking on metabolic syndrome and its components using causal methods in the Iranian Population
title_full_unstemmed The effects of smoking on metabolic syndrome and its components using causal methods in the Iranian Population
title_short The effects of smoking on metabolic syndrome and its components using causal methods in the Iranian Population
title_sort effects of smoking on metabolic syndrome and its components using causal methods in the iranian population
topic metabolic syndrome
propensity score
smoking.
url http://www.ijpvmjournal.net/article.asp?issn=2008-7802;year=2021;volume=12;issue=1;spage=118;epage=118;aulast=Khodamoradi
work_keys_str_mv AT farzadkhodamoradi theeffectsofsmokingonmetabolicsyndromeanditscomponentsusingcausalmethodsintheiranianpopulation
AT maryamnazemipour theeffectsofsmokingonmetabolicsyndromeanditscomponentsusingcausalmethodsintheiranianpopulation
AT nasrinmansournia theeffectsofsmokingonmetabolicsyndromeanditscomponentsusingcausalmethodsintheiranianpopulation
AT kamranyazdani theeffectsofsmokingonmetabolicsyndromeanditscomponentsusingcausalmethodsintheiranianpopulation
AT davoodkhalili theeffectsofsmokingonmetabolicsyndromeanditscomponentsusingcausalmethodsintheiranianpopulation
AT mohammadalimansournia theeffectsofsmokingonmetabolicsyndromeanditscomponentsusingcausalmethodsintheiranianpopulation
AT farzadkhodamoradi effectsofsmokingonmetabolicsyndromeanditscomponentsusingcausalmethodsintheiranianpopulation
AT maryamnazemipour effectsofsmokingonmetabolicsyndromeanditscomponentsusingcausalmethodsintheiranianpopulation
AT nasrinmansournia effectsofsmokingonmetabolicsyndromeanditscomponentsusingcausalmethodsintheiranianpopulation
AT kamranyazdani effectsofsmokingonmetabolicsyndromeanditscomponentsusingcausalmethodsintheiranianpopulation
AT davoodkhalili effectsofsmokingonmetabolicsyndromeanditscomponentsusingcausalmethodsintheiranianpopulation
AT mohammadalimansournia effectsofsmokingonmetabolicsyndromeanditscomponentsusingcausalmethodsintheiranianpopulation